Literature DB >> 3950960

Distribution of sero-biotypes of Campylobacter jejuni and C. coli isolated from paediatric patients.

A J Lastovica, E Le Roux, R V Congi, J L Penner.   

Abstract

During a one-year period, 258 isolates of Campylobacter jejuni and C. coli were obtained from children with gastroenteritis or bacteraemia at the Red Cross Children's Hospital, Cape Town, South Africa. These isolates were biotyped by hippurate hydrolysis, H2S production and tolerance to 2,3,5-triphenyltetrazolium chloride (TTC). Our study indicated that 95.4% of the isolates were C. jejuni biotype 1, 1.5% were C. jejuni biotype 2 and 3.1% were C. coli; 70% of the isolates were resistant to TTC. Serotyping on the basis of soluble, thermostable antigens detected by a passive-haemagglutination technique revealed that 79% of the Cape Town isolates were typable and that the most common serotypes, in order, were: 4, 2, 12, 23/36 and 19, together comprising 25% of the isolates. About 37% of the typable isolates belonged to nine serotypes. The finding that 21% of the isolates were non-typable suggests the existence of antigenic specificities different from those defined by the 60 antisera in current use.

Entities:  

Mesh:

Year:  1986        PMID: 3950960     DOI: 10.1099/00222615-21-1-1

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndrome.

Authors:  T M Wassenaar; B N Fry; A J Lastovica; J A Wagenaar; P J Coloe; B Duim
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Identification of Campylobacter heat-stable and heat-labile antigens by combining the Penner and Lior serotyping schemes.

Authors:  David L Woodward; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 3.  Campylobacter bacteremia: a rare and under-reported event?

Authors:  R Louwen; P van Baarlen; A H M van Vliet; A van Belkum; J P Hays; H P Endtz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

Review 4.  The genus Campylobacter: a decade of progress.

Authors:  J L Penner
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 5.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

6.  Molecular subtyping by genome and plasmid analysis of Campylobacter jejuni serogroups O1 and O2 (Penner) from sporadic and outbreak cases of human diarrhoea.

Authors:  A Fayos; R J Owen; J Hernandez; C Jones; A Lastovica
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

7.  "Campylobacter upsaliensis" isolated from blood cultures of pediatric patients.

Authors:  A J Lastovica; E Le Roux; J L Penner
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

8.  Serotype distribution of Campylobacter jejuni and Campylobacter coli isolated from hospitalized patients with diarrhea in central Australia.

Authors:  M J Albert; A Leach; V Asche; J Hennessy; J L Penner
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  Comprehensive ribotyping scheme for heat-stable serotypes of Campylobacter jejuni.

Authors:  C Fitzgerald; R J Owen; J Stanley
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 10.  Campylobacter polysaccharide capsules: virulence and vaccines.

Authors:  Patricia Guerry; Frédéric Poly; Mark Riddle; Alexander C Maue; Yu-Han Chen; Mario A Monteiro
Journal:  Front Cell Infect Microbiol       Date:  2012-02-15       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.